Table 2 Number of tumor-free mice per vaccine group after challenge and re-challenge
From: Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Vaccine group | Tumor-free mice after | |
|---|---|---|
1st challenge | 2nd challenge | |
Mock | 2/10 | 0/2 |
BC-FAST | 7/10 | 1/7 |
BC-PCV | 5/10 | N/T |
PC-FAST | 3/10 | 0/3 |
NR-PCV | 5/5 | N/T |
BC-FAST/ICI | 4/10 | 1/4 |
BC-PCV/ICI | 3/10 | N/T |
PC-FAST/ICI | 4/10 | 0/4 |
NR-PCV/CI | 2/10 | N/T |